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ABSTRACT
Artificial redox enzymes are disclosed wherein one or

more redox coenzymes or cofactors are linked to the
2-O, 3-O or 6-O positions of a D-glucopyranose ring of
a-, 3-, or y-cyclodextrins. Also disclosed are facile
synthetic methods for producing said artificial redox
enzymes in good yield, and methods of use of such
compositions.
26 Claims, 25 Drawing Sheets
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Cold Soring Harbor Symposium on Quantitative Biology,

ARTIFICIAL REDOX ENZYMES

52:75-81 (1987).

As noted above, enzymes operate by binding a sub
strate and then performing a selective catalyzed reac
1. Field of the Invention
tion within the enzyme-substrate complex. The geome
This invention relates to non-proteinaceous organic try of the complex and the geometric placement of
molecules that exhibit the catalytic and kinetic proper various catalytic functional groups help determine both
ties of enzymes. More particularly, this invention relates the rates and the specificities of the reaction. Among
to cyclodextrin-coenzyme and cyclodextrin-cofactor artificial enzymes, a generally useful type of binding
conjugates that behave catalytically and kinetically as 10 appears to be hydrophobic inclusion within a cavity.
do oxidation-reduction ("redox') enzymes.
Breslow et al., 1970 above, showed how hydrophobic
2. Description of the Related Art
binding in a cavity could be used to bring a simple
Enzymes are proteins with catalytic activity that organic compound close enough to a metal to permit
exhibit high specificity and large rate accelerations. 15 metal-catalyzed reactions, even though the substrate
Although enzymes are large and complex molecules, itself is not a normal metal ligand.
their power to catalyze chemical reactions can be attrib
The ideal artificial enzyme should not only have a
uted mainly to binding of reactants and catalysis. Bind cavity that provides maximum hydrophobic interaction
ing not only is largely responsible for the specificity of with a substrate to form complexes, but the cavity
the reaction but, by stereochemistry, also brings the 20 should fit bulky components of the substrate such as
substrate in close proximity to and in the correctorien aromatic rings, and orient the functional group of the
tation with the active site(s) of the enzyme. Other fac bound substrate toward the attacking atom or group.
BACKGROUND OF THE INVENTION

tors, such as the microenvironment of the catalytic site
and the stabilization of the transition state by hydrogen
bonding, contribute to enzyme activity, but binding
(seen particularly in transition-state analogues) and ca 25
talysis are the two essential features of all enzymes. See,

for a review of enzymes, Dixon, M., and Webb, E. C.,
Enzymes, Academic Press, N.Y., 1979.
An additional substance besides the enzyme and sub
strate is required in many cases in order that the reac
tion may proceed. Although such substances, variously

30

referred to as "cofactors' or "coenzymes' may participate

in the intermediate steps of the reaction catalyzed by the
enzyme (or the cycle of reactions catalyzed by a system

of enzymes), they are not consumed during the process,

35

D'Souza, V. T. et al., Acc. Chem. Res., 20:146-152
(1987).

The cyclodextrins are cyclic molecules with a rela

tively hydrophobic interior cavity and hydroxyl groups
that make them water soluble. Bender, M. L., et al.,
Cyclodextrin Chemistry, Springer-Verlag, N.Y. 1977;

Tabushi, I., Acc. Chem. Res., 15:66 (1982). Cyclodex
trins consisting of 6 (a-cyclodextrin or cyclohex
aamylose), 7 (8-cyclodextrin or cycloheptoamylose)
and 8 (y-cyclodextrin or cyclooctaamylose) units of
a-1,4-linked D-glucopyranoses are known. Cyclodex
trins have doughnut shapes with secondary hydroxyl
groups at the C-2 and C-3 atoms of glucose units dis

posed in the more open end and primary hydroxyl

but are found in their original form at the end of the groups at the C-6 atom of the glucose unit located at the
catalysis. They may, therefore, be regarded as an essen other end (1).
tial part of the catalytic mechanism.
The majority of coenzymes and cofactors act in one
6
(1)
of the following ways: (a) as inter-enzyme carriers; (b)
as a prosthetic group, which often is an intraenzyme
carrier (e.g., heme, flavin, nicotinamide, pteridines,
coenzyme Q, a metal atom or ion, etc.) covalently or
electrostatically bound to the enzyme protein as an 45
O3 2 O
essential part of the enzyme; (c) by altering the shape of
the enzyme molecule; (d) by subunit aggregation; (e) as
OH
stabilizers; (f) as templates; (g) as primers; and (h) as
(Glu)

intermediates.

Enzymes are labile molecules, and this lability limits 50
their industrial usefulness. They are sensitive to heat
and pressures which, in the extreme, can reduce or
destroy catalytic activity and, in the further extreme,
can denature and precipitate the enzyme protein. Many
enzymes are also sensitive to extremes of pH which can 55
irreversibly inactivate the enzyme. The presence of
proteolytic enzymes, whether of bacterial or other ori

gins, will also reduce or destroy the effectiveness of
enzymes. Certain heavy metal ions may also inactivate
enzymes. For these reasons, non-protein artificial en 60
zymes that are not subject to these problems have been
sought for many years.
Non-protein artificial enzymes, also referred to as
miniature organic models of enzymes, have been known
since about 1970 when Breslow et al. disclosed an "arti 65
ficial enzyme combining a metal catalytic group and a
hydrophobic cavity'. Breslow, R., et al., J. Am, Chem.
Soc. 92: 1075 (1970). See also, for a review: Breslow, R.,

( )

1.

where n=6, 7 or 8. The interior of the cavity, consisting
of a ring of C-H groups, a ring of glycosidic oxygen
atoms, and another ring of C-H groups, is hydropho
bic in nature. The inner diameters of the cavities are
approximately 4.5 A in a-cyclodextrin, 7.0 A in B
cyclodextrin and 8.5 A in y-cyclodextrin. D'Souza et
al., 1987, above. a- and g-Cyclodextrins would provide
a Snug fit for an aromatic ring. Formation of inclusion

complexes with various substrates (binding) is one of
the most important characteristics of cyclodextrins.
Bender, M. L., et al., Ady. Enzymol. Relat. Areas Mol
Biol, 58:1 (1986).
Breslow et al. (Breslow, R., et al., J. Am. Chem. Soc,

105:1390-1391 (1983)), have produced a 'synthetic
transaminase' enzyme wherein the coenzyme pyridox
amine is linked to the C-6 of 6-cyclodextrin, thereby
putting it on the more narrow primary end of the struc
ture. The artificial enzyme is reportedly able to tran
Saminate keto acids, with a preference for keto acids

5,258,370
3
4.
containing an hydrophobic aromatic group, e.g., phe mildly basic conditions that are required to attach the
nylpyrunic acid. The coenzyme was also attached to the coenzyme to the 6-position of cyclodextrin by the dis
secondary face of the molecule via the C-3 hydroxyl closed process (see below in Detailed Description of the
group, but, although this molecule reportedly also cata Invention).
lyzes transamination and also prefers aromatic keto
Thus, a great need exists for highly active and stable,
acids as substrates, the secondary-side derivative is only readily
inexpensively synthesizable artificial redox
about half as effective as is the primary side analogue. enzymes.andThis
Further, the primary-side derivative gives a preference disclosed below.need has been fulfilled by the invention
for the synthesis of the natural (in vertebrates) L-enanti
omers of amino acids, whereas the secondary-side de O
SUMMARY OF THE INVENTION
rivatives give a preference for the synthesis of the un
We have chemically synthesized artificial redox en
natural D-product.
zymes
derivatives of cyclodextrins that
D'Souza et al. (D'Souza, V. T., et al., Biochem. Bio catalyzecomprising
the
same
reactions
natural protein redox
phys. Res. Commun., 129:725 (1985)) have synthesized a enzymes, such as oxidation asanddohydride
transfers, but
"synthetic chymotrypsin' proteolytic enzyme wherein 15
which
are
devoid
of
the
limitations
of
protein
enzymes
o, g and y-cyclodextrins are functionalized by derivati such as instability in the presence of high temperatures
zation at the secondary-side 2-hydroxyl group with o

mechanical stress, organic solvent and
4(5)-mercaptomethyl-4(5)-methylimidazol-2-yl) ben or pressures,
conditions, and proteolytic enzymes.
zoic acid, to produce a derivative designed to mimic the detergent
It is thus an object of this invention to provide novel
active site of chymotrypsin itself. The artificial and 20 artificial
redox enzymes.
natural enzymes are reportedly comparable in their
It is another object of this invention to disclose the
catalytic activity, Further, whereas the real chymotryp
sin has an optimal temperature around 45 C., it precipi chemical synthesis of such novel artificial enzymes.
It is yet another object of this invention to disclose
tates after about 55 C. and is rendered inactive; in con
trast, the activity of the artificial enzyme keeps increas 25 uses to which these artificial enzymes may be put.
It is still another object of this invention to disclose
ing to at least 80 C.
Breslow et al. (Breslow, R., et al., J. Am. Chem. Soc, means for altering the solubility characteristics of cy
100:3225 (1978)) constructed 6-cyclodextrinyl bisimida clodextrin artificial redox enzymes.
These and other objects will become apparent by
zole which is a model for the ribonuclease enzyme. In
reference to the specification and to the appended
this artificial enzyme, the bisimidazole is linked to two 30 claims.
of the primary-side 6-hydroxyl groups of the A3
cyclodextrin, forming a bifunctional catalytic site. The
BRIEF DESCRIPTION OF THE DRAWINGS
artificial enzyme was reportedly slow compared to
FIG. 1 shows the structure of a flavocyclodextrin
ribonuclease itself, although exhibiting characteristics
of the enzyme.
35 artificial enzyme bound to a dihydronicotinamide sub
The class of protein enzymes referred to variously as Strate.
oxidoreductases or redox enzymes includes enzymes
FIG. 2 shows a H NMR spectrum of structure 3 in
concerned with biological oxidation and reduction, and Example 1.
FIG. 3 shows a 13C NMR spectrum of structure 3 in
therefore with respiration, fermentation, and metabo
lism in general. Oxidoreductases include (a) dehydroge Example 1.
nases and oxidases that employ, e.g., AND, NADP,
FIG. 4 shows a 1H NMR spectrum of structure 4 in
FMN and electron-transferring flavoproteins, as coen Example 1.
zymes; (b) peroxidases that can be iron-containing heme
FIG. 5 shows a 13C NMR spectrum of structure 4 in
proteins or flavoproteins; and (c) oxygenases or hy Example 1.
droxylases that can be flavoproteins, use pteridines or 45 FIG. 6 shows a 13C NMR spectrum of structure 5 in
2-oxoglutamate as coenzymes, or use copper ions as an Example 1.
oxidation / reduction pair. Such enzymes have great
FIG. 7 shows a 13C(APT) NMR spectrum of struc
medical and industrial potential. However, such appli ture 5 in Example 1.
cations are limited by the instability of these enzymes to
FIG. 8 shows a H NMR spectrum in CDCl3 of struc
high temperatures and pressures, mechanical stress, 50 ture 8 of Example 2.
organic solvents and detergent conditions. Thus, artific
FIG. 9 shows a H NMR spectrum in DMSO-d6 of
ial redox enzymes that carry out the catalytic functions structure 9 of Example 2.
of natural redox enzymes but that are stable to the con
FIG. 10 shows a 1H NMR spectrum in DMSO-d6 of
ditions noted above, would be extremely valuable.
structure 10 of Example 2.
Limited success has been achieved with an artificial 55 FIG. 11 shows a H NMR spectrum in DMSO-d6 of
flavoenzyme. Tabushi et al. (Tabushi, I., et al., J. Am. structure 12 of Example 2.
Chem. Soc., 109:4734-4735 (1987)) reported the synthe
FIG. 12 shows a 13C NMR spectrum in DMSO-d6 of
sis of an artificial flavoenzyme, flavo-a-cyclodextrin in structure 12 of Example 2.
which the 8-position of the flavin is attached to the
FIG. 13 shows a H NMR spectrum in DMSO-d6 of
primary-side 6-position. This molecule reportedly structure 13 of Example 2.
carries out electron transport, although it was also dis
FIG. 14 shows a 13C NMR spectrum in DMSO-d6 of
closed in this report that the natural NADH-dependent structure 13 of Example 2.
flavoprotein enzyme exhibits a rate constant 30-fold
FIG. 15 shows a H NMR spectrum of 6-cyclodex
greater than that of the artificial enzyme, and the natu trin.
ral flavoprotein exhibits an association constant for 65 FIG. 16 shows a CNMR spectrum of a-cyclodex
NADH 8-fold greater than does the artificial enzyme. trin.
In addition, the reported chemical synthesis of this arti
FIG. 17 shows a 1H NMR spectrum of the o
ficial is difficult, as the riboflavin decomposes under the cyclodextrin analogue of structure 12 of Example 2.

5

5,258,370

FIG. 18 shows a 13C NMR spectrum of the a
cyclodextgrin analogue of structure 12 of Example 2.
FIG. 19 shows a 13C(APT) NMR spectrum of the
a-cyclodextrin analogue of structure 12 of Example 2.
FIG. 20 shows a 1H NMR spectrum of the a
cyclodextrin analogue of structure 13 of Example 2.
FIG. 21 shows a 13C NMR spectrum of the a
cyclodextrin analogue of structure 13 of Example 2.
FIG. 22 shows a 13C(APT) NMR spectrum of the
a-cyclodextrin analogue of structure 13 of Example 2.
FIG. 23 shows the kinetics of the oxidation of benzyl
mercaptain by riboflavin (A) and by 2-flavo-f6-cyclodex

6

2',3',4',5'- tetracetylriboflavin (BrT f) (Lemuel, B. W.
et al., J. Mol Cat., 9:209 (1980); Walker, W. H., et al.,

Eur. J. Biochem, 26:279 (1972)) under a variety of

conditions.

TABLE 1.

Biochemical transformations involving flavin Coenzyme

Chemical transformation

Examples
D-Lactate

10

dehydrogenase,
Glucose oxidase,

Thiamine

dehydrogenase

trin (B).
FIG. 24 shows the Lineweaver-Burk plot of the oxi

N

dation of benzyl mercaptan by 2-flavor-g-cyclodextrin.
FIG. 25 shows the Lineweaver-Burk plot of the oxi
dation of the dihydronaphthylnicotinamide by 2-flavor
fe-cyclodextrin.

-H-NH. ->c=o + NH4

DETAILED DESCRIPTION OF THE
20
INVENTION
We have invented useful and novel artificial redox

N

-H-H-C=O -> /c=t-=o dehydrogenase,
E
Dihydrooroate
dehydrogenase
NADH

dehydrogenase,
transhydrogenases,
Dihydrooratate
dehydrogenases,
NADH-dependent
monoxygenases

anchors the substrate molecule at the site at which the 30

catalytic site to catalyze redox reactions,
A schematic drawing of one such novel artificial
redox enzyme is shown in FIG. 1. In this molecule,
dihydropyridine (the "working end of AND and

Amine oxidases

Succinate
dehydrogenase,

enzymes and methods for the chemical synthesis of such
molecules based on the chemistry of biological redox
enzymes.
25 NADH -GNAD+
As noted above, binding and catalysis are the major
features that enable protein enzymes to bring about
chemical transformations with large acceleration and
high specificity. D'Souza et al. 1987 above. Binding
reaction is intended to occur and catalysis lowers the
energy barrier of the reaction and enables the reaction
to occur at lower temperatures and at a faster rate. The
artificial redox enzymes designed and synthesized here
contain a binding site to bind specific substrates and a

D- and L-amino
acid oxidases,

Lipoamide

HS

SH

S

35

S

dehydrogenase,
Glutathione
reductase

p-Hydroxybenzoate
hydroxylase
Phenol hydroxylase

NADP) non-covalently bound to cyclodextrin is shown
as being oxidized by hydride ion transfer to a flavin
covalently attached to the secondary side of cyclodex

Cyclopenatanone
monooxygenase

tin.

As the secondary side of cyclodextrin is the preferred
side for the binding of substrates (Van Etten, R. C., et 45
al., J. Am. Chem. Soc., 69:3242 (1967)), it is an important
aspect of this invention that the novel flavocyclodex
trins, wherein the flavin moiety is attached to this side,
act as a more efficient artificial redox enzyme than do
their primary side counterparts.
50
Flavin is a co-factor in seven categories of enzymes:
dehydrogenases, oxidases, oxido-decarboxylases, mo
nooxygenases, dioxygenases, metalloflavoenzymes and
flavodoxins. These enzymes catalyze a variety of chem
ical transformations such as those shown in Table 1. 55

Thus, the artificial flavoenzymes described here will be
invaluable in processes such as those that require the
chemical transformations listed in Table 1.
The synthesis of 6-flavo-a-cyclodextrin according to
Tabushi et al. 1987, above, did not yield product. 6
Deoxy-6-thioaceto-g-cyclodextrin (1), synthesized
from the known 6-tosyl-(3-cyclodextrin (Melton, L. D.,
et al., Carb. Res., 19:29 (1971) and potassium thioace

tate, was hydrolyzed to 6-deoxy-thio-g-cyclodextrin
(2). The physical constants and H NMR spectra of 2
were identical to those previously reported (Fujita, K.,
Biorg. Chem., 11:73 (1982); D'Souza, V. T., et al., 1985
above). 2 was allowed to react with 8-a-bromo

R-CHO-GR-Coo-

Luci

uciferase

Although TLC data indicated that some reaction has

taken place, H and 13C NMR spectra of the isolated
products indicated a mixture of compounds formed by
decomposition of flavin and unreacted 2.
An attempt was made to synthesize 6-flavo-6-

cyclodextrin by a nucleophilic attack of a flavin deriva
tive on 6-iodo-6-cyclohdextrin 3 in Scheme I below.
However, the synthesis of the nucleophilic flavin deriv

ative, 8-a-thio-tetracetylriboflavin,by the reaction of
potassium thioacetate with BrTfl and subsequent hy
drolysis failed. The flavin derivative decomposed dur

65

ing the initial reaction, and no product could be de
tected. We discovered that flavin derivatives decom
posed rapidly even under mildly basic conditions, and
this property makes unusable previously reported meth
ods of synthesizing flavocyclodextrins (Tabushi et al.,
1987, above).
In the following disclosures, cyclodextrin will be
abbreviated as CD.

5,258,370
8
N-alkyl-5-haloalkyl-2-nitroaniline,
N-aryl-5-haloalkyl
the synthesis of flavocyclodextrins which involves con 2-nitroaniline, N-alkyl-2-amino-5-haloalkylaniline, N
structing the flavin moiety from precursors previously aryl-2-amino-5-haloalkylaniline, N-alkyl-6-haloalkyl-2attached to the CD. In Scheme I, below, reaction of nitroaniline, N-aryl-6-haloalkyl-2-nitroaniline, N-alkyl
6-iodo-CD (3) with o-phenylenedianine will yield 6-(o- 5
N-aryl-2-amino-6-haloalk
phenylenediamino)-CD (4). Reaction of 4 with alloxan 2-amino-6-haloalkylaniline,
ylaniline,
haloalkyl,
(haloalkyl)aryl,
alkylsulfonyl hal
monohydrate will produce the desired flavo-CD (5).
The a-1,4-glycosidic bonds of CD will not hydrolyze ide, arylsulfonyl halide, acyl halide, acyl anhydride,
under acidic reaction conditions. The 6-flavo-g-CD acid halide, acid anhydride, and alkylepoxide. Suitable
7
We have discovered a superior and facile method for

thus obtained can be analyzed by H and 13C NMR.

c) CI

O

NH2

substituents on the phenyl moiety in accordance with

this invention may include alkyl, aryl, halo, amino, and
mono- and di-substituted amino groups.
OH OH

NH2

II

2

15

N-1

NaH G

6

CH2OH

20

RX is an electrophilic reagent; X is a leaving group and R is the desired functional

group

The more-important and preferred 2-flavo-CD's can
be synthesized as shown in the general method of

Scheme II. It involves the removal of a single proton
from the hydroxyl group at the 2-position of CD (1)
based on its acidity using dry DMF and NaH to yield
(2), followed by a nucleophilic substitution of the resul
tant oxyanion by the desired electrophile to give CD
mono-substituted at the 2-O position (3). This method is
a general method that can be used to attach any cata
lytic site to the more important catalytically secondary
side of CD's. Other suitable hydroxyl proton removing

reagents include metal hydroxides, metal alkoxides,
alkali metals, and organometallic compounds. Suitable
RX electrophilic reagents include phenyl unsubstituted
or substituted N-alkyl-4-haloalkyl-2-nitroaniline, N
aryl-4-haloalkyl-2-nitroaniline,
N-alkyl-2-amino-4haloalkylaniline, N-aryl-2-amino-4-haloalkylaniline,
N-alkyl-2-amino-4-haloalkylaniline, N-aryl-2-amino-4haloalkylaniline, N-alkyl-3-haloalkyl-2-nitroaniline, N
aryl-3-haloalkyl-2-nitroaniline,
N-alkyl-2-amino-3haloalkylaniline, N-aryl-2-amino-3-haloalkylaniline,

An example of the construction of the flavin moiety

50

on the secondary side of CD is shown in Scheme III.
4-Chloro-3-nitro-benzaldehyde is reacted with me

thylamine to yield 4-(methylamino)-3-nitrobenzalde
55

hyde (8) which is then reduced by NaBH4 to N-methyl
4-hydroxymethyl-2-nitroaniline (9). Reaction of SOC
with 8 will give N-methyl-4-chloromethyl-2-nitroani
line (10). Structures of 8, 9 and 10 may be characterized
by H NMR and elemental analysis. 10 is used as an
electrophile to react with sodium CD alkoxide (11) to

yield 2-O-(4-methylamino-3-nitro) benzyl-6-CD (12).

The addition of 10 to 11 is a novel method for mono

65

functionalizing the 2-position of CD's (Rong, P., and
D'Souza, V.T., Tetrahedron Lett, 31:4275 (1990)). 12 is
hydrogenated by agents such as H2/Pd, H2/Pt, H2/Ni,
Sn/HCl, Fe/HCl and Zn/HCl, and then condensed
with alloxan monohydrate to yield 2-flavo-CD (13).
Compounds 11 and 12 can be characterized by 1H and

13C NRM. 2-Flavo-a-CD, 6-CD and y-CD may be

synthesized by the same method.
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10
remaining hydroxy groups may be derivatized to, e.g.,
II
O-alkyl, O-acyl, O-aryl, O-alkylsulfonyl, O-arylsulfonyl
or O-(trialkylsilyl) groups. This will increase the hydro
phobicity of the artificial enzyme, thereby increasing
NaBH, Ge. 5 the reactivity with hydrophobic substrates and increas
ing the solubility of the artificial enzyme in less-hydro
philic solvents. In addition, an N-alkyl substituted al
loxan, e.g., N-methylalloxan, can be used instead of
alloxan to increase the stability of the artificial redox
O
enzyme. Other suitable N3-substituent groups on the
alloxan include aryl, acyl, alkylsulfonyl and arylsul
NHCH3
fonyl groups. The chain length of the linker between
NO2 the CD and the flavin may be varied by using higher
15 homologues of the benzyl chloride derivative 10. Alkyl
groups other than methyl, as well as aryl, chloro,
bromo, iodo, fluoro, amino, and mono- and di-sub
stituted amino groups, may be used as substituents on
C
the amino group of the o-phenylenediamine moiety.
10
20 Although flavo-CD artificial redox enzymes have
been used to illustrate this invention, it should be em
phasized that the concept of the invention is generally
applicable to any artificial redox enzyme using CD as
the matrix. For example, covalently bound coenzymes
25 such as nicotinamide, heme, pteridines, and coenzyme
Q and electrostatically bound cofactors such as chro
mium, manganese, iron, cobalt, nickel, copper, zinc,
rhodium, osmium, palladium and platinum ions may be
bound to the primary or secondary sides of a CD mole
30 cule in order to carry out appropriate redox reactions.
Although it has been convenient to illustrate the arti

H2/Pd

O - N.

\7
12

-->
N
O

C

N

NH

O

H.

N

N

ar Ne
a

NH
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ficial redox enzymes of the invention with a single coen
zyme covalently bound to one or another ring carbon
atom of the glucopyranose of a cyclodextrin, it is within
the spirit and scope of the invention to have two or
three different redox coenzymes and cofactors linked to
the same or other glucopyranose rings at different posi
tions, i.e., at the 2-, 3-, and 6-positions. Such multiple
coenzymes may be used to carry out sequential reac
tions in a synthetic scheme, such as an oxidation at the
site and substrate subsite of one coenzyme and a reduc
tion of the product at a different pair of sites using a
second coenzyme or cofactor. For example, pairs or
triplets of the aforementioned redox coenzymes and

cofactor metal ions may be attached to appropriate
positions on one or more glucopyranose rings of cy
clodextrins to carry out sequential redox reactions.
The artificial redox enzymes of the invention have
particular utility as industrial catalysts. That is, they
50 may advantageously be employed to carry out oxida
tions and/or reductions in synthetic processes, and,
because of their inherent stability relative to their natu
ral counterpart enzymes, they may be employed in high
The most important feature of this synthesis is the temperature
or pressure applications, thereby increas
condensation of alloxan with the substituted diamine 55 ing
yields of products. For example, the artificial en
under acidic conditions. Contrary to theoretical expec
tations, CD was found to be stable under such condi zymes of the invention may be attached to the inner
tions, and produces good yields of isolated and purified surface of a thermojacketed tube, the reactants pumped
flavin 13. This has opened a new and simple route for through the tube at appropriate rates and with appropri
the synthesis of modified flavo-CDs by condensing a ate means to place reactants in contact with the artificial
modified alloxan with 2-O-(4-methylamino-5-nitro) ben enzymes, and products drawn off at the other end of the
zyl-CD, 12. Although the general reaction is exempli tube. Alternately, the artificial enzymes of the invention
fied with 2-O-(4-methylamino-5-nitro) benzyl-CD (12), may be used in a batch mode, wherein the artificial
any benzyl derivative may be used provided that there enzyme(s) is (are) attached to the inner surface of a
is a nitro group ortho to the amino group.
thermojacketed reaction vessel, reactants added with
N

O

Many modifications of this basic invention are possi 65 mixing, and products isolated from the reaction mix
ble without departing from the concept and Scope of ture.
this invention. For example, the flavin molecule may be
attached to the secondary side of a CD, and all of the

Such artificial catalysts of the invention may also be
used to perform reactions for which no natural enzymes
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occur. Many of the most important chemical processes
of interest in chemical manufacturing, for instance, are
not processes that are performed enzymatically in na
ture. However, appropriate artificial redox enzymes
could be prepared by the methods of the invention, and
these compositions could in principle perform these
useful chemical reactions with an enzymatic style and
with the resultant advantages of selectivity and rate
characteristic of this style.
The examples that follow provide several embodi 10
ments of the synthetic routes to the artificial redox

enzymes of the invention, the chemical and physical
properties of such compositions, and the kinetic proper
ties of the molecules. These examples are illustrative
only and are not intended in any way to limit the scope

N.

CC

Mono-6-0-(o-phenylenedianino)-(3-cyclodextrin (4).

3, 2.2 g (1.8 mmol), was reacted with 4.4 g (41 mmol) of
o-phenylenediamine in DMF at 110° C. for 3 hours
under nitrogen. The product formed was precipitated
with 400 ml acetone. After filtration, the precipitate was
redissolved in 40 ml water and then extracted with 50
ml chloroform. After addition of 300 ml acetone to the

20

aqueous layer, the precipitate was collected to yield 2.1
g (94%) of 4. TLC of the product indicated a single
compound. Hand 13C NMR spectra indicated that one
o-phenylenediamine molecule was attached to the 6
position of 3-cyclodextrin. 300 MHz H spectrum
showed all the peaks of 3-cyclodextrin and multiplets of
aromatic peaks of o-phenylenediamino moiety at

EXAMPLE I

- N.

in 100 ml DMF at 80 C. for 2.5 hours. After the volume

of the solution was reduced to 6 ml by evaporation, 200
ml of absolute ethanol was added and then stirred over
night. Collection of the precipitate formed gave 3 in a
pure form.

S

of the invention, which is provided by the specification
and appended claims.

Synthesis of Mono-6-flavo-g-cyclodextrin 5

12

Mono-6-O-iodo-g-cyclodextrin (3). It was synthe
sized by the reaction of 5.0 g (30 mmol) of potassium
iodide with 1.9 g (1.5 mmol) of 6-tosyl-6-cyclodextrin

25

-NH2 G
30

35

45

6.3-6.6 ppm. 13C NMR spectrum showed all the normal

peaks of 9-cyclodextrin at 60.4, 72.0, 72.5, 73.5, 81.7 and
102.4; the peaks for the substituted glucose of cyclodex

trin at 45.3, 70.0, 81.0, 84.5 and 101.6 and the six peaks
for the o-phenylenediamino moiety at 111.1, 114.8,
117.6, 118.1, 135.6 and 136.3
Mono-6-flavo-g-cyclodextrin (5). Reaction of 500 mg
of 4 with 1.0 g of alloxan monohydrate in 20 ml 1 NHCl
for 30 minutes at 60° C. afforded the desired flavocy
clodextrin. Cyclodextrin derivatives were precipitated

from the reaction mixture and recrystallized from a
minimum amount of water. The crystals were further
purified by C18-HPLC to give pure 6-flavocyclodex
trin. 300 MHz 1H NMR spectrum of the purified prod
uct showed all the signals for 6-cyclodextrin and the
aromatic signals of the flavin moiety at 8 7.6, 7.9, 8.09
and N-3 at 8 11.25. 13C NMR spectrum showed all the
normal peaks of £3-cyclodextrin at 60.2, 72.1, 72.6, 73.0,
81.8, 102.0 ppm from TMS; the peaks for the substitute
glucose unit of g-cyclodextrin at 46.5, 66.9, 71.5-75,
84.6 and 102.8 (which match well with the 13C chemical
shifts for the ribityl group of riboflavin) and 10 signals
for flavin at 117.8, 125.9, 131.4, 134.1, 134.3, 1348,
138.6, 150.7, 155.5, 159.7.

50

FIGS. 2 and 3 are NMR spectra in H and 13C, re
spectively, of 3.

FIGS. 4 and 5 are NMR spectra in H and 13C, re

N

2 N Ne

spectively, of 4.
FIGS. 6 and 7 are NMR spectra in 13C and

13C(APT), respectively, of 5.

N-H 55

al

N

EXAMPLE 2

Synthesis of Mono-2-flavo-g-cyclodextrin 12

O

1H and 13C NMR spectra were obtained from a Va
rian XL-300 spectrometer. TMS was used as an internal

C

was the solvent. All the Rf values were obtained using

TLC on silica plates with the solvent: n-butanol:ethanol:water=5:4:3 by volume.
65
6-Mono-tosyl-g-cyclodextrin. It was synthesized ac
cording to Saenger, W., Angew, Chem. Int. Ed., 19:334
(1980).

NHCH

NO2

reference when the CDCl3 or DMSO-dg was the sol
vent. TMS was used as an external reference when D2O

NO2

NaBH4 G
2
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2-O-(4-Methylamino-3-nitro)benzyl-6-cyclodextrin

30

CH3

N

\)

2 N Ne

I
O

35

40
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4-Methylamino-3-nitro-benzylaldehyde (8). To a 30
ml ethanol solution containing 4.0 g (22 mmol) of 4 45
chloro-3-nitrobenzylaldehyde (7), 50 ml aqueous me
thylamine solution (40%) was added and the solution
was then refluxed for three hours; the precipitate was
collected after being cooled in a refrigerator overnight.
The precipitate was then washed with water and then 50
dissolved in 400 ml 1N HCl and stirred overnight. The

precipitate was filtered, washed with water to yield 3.2
g (81%) of yellow 8, mp:173.5-1750 C. H

NMR:(CDCl3) 8 9.78 (s, 1H, CH=O), 8.64 (d. 1H,
J-19 Hz, H-2), 7.97 (dd, 1H, J =9, 1.5 Hz, H-5) HCH 55
5), 6.94(d, 1H, J=9 Hz, H-5), 3.11(d, 3H, J=5.2 Hz,
CH3), 8.54 (broad, 1H, NH). Anal. Calcd for
CHNO3:C, 53.33; H, 4.48; N, 15.55; O, 26.64; found:
C, 53.45; H, 4.55; N, 15.58; O, 26.42.
4-Methylamino-3-nitro-benzylalcohol (9), 0.32 g (8.3
immol) of sodium borohydride was added to 20 ml abso
lute alcohol solution containing 3.0 g (16.6 mmol) of 8.
The suspension was stirred for 3 hours. The Solution
was then cooled in an ice/water bath, and 8.5 ml 2N
HCl was added dropwise to the solution to decompose
unreacted sodium borohydride. The pH of the solution 65
was adjusted to 10 by adding about 10 ml of concen

trated ammonium hydroxide and then extracted with 60
ml chloroform three times. After being dried over mag

NH), 8.15 (d, 1H, J=2.2 Hz, H-2), 7.60p, 1H, (dd, 1H,
J=8.9, 2.2 Hz, H-6), 7.01 (d, 1H, J =9.0 Hz, H-5), 4.76
(s, 3H, CH2), 2.95 (s, 3H, CH3). Anal. Calcd for
C8H9N2O2Cl: C, 47.89; H, 4.52; Cl, 17.67; N, 14.00; O,
15.95, found: C, 47.78; H, 4.49; Cl, 17.78; N, 13.82; O,
16.13.

NH

O

N

mmol) of 9 was dissolved in 25 ml thionylchloride at
-78 C. cooled with dry ice/acetone bath. After it
dissolved completely, the dry ice/acetone bath was
removed and the reaction mixture allowed to warm up
to room temperature and kept at room temperature for
additional 1 hour. Thionylchloride was evaporated
under vacuum at room temperature and the residue was
washed with 5 ml cold diethylether and recrystallized
from diethylether to yield 0.6 g (55%) of 10. Yellow,

mp: 126-128 C. 1H NMR: (DMSO-d6): 8 82.9 (s, 1H,

NO2

O -N

14

nesium sulfate and evaporated, the residue was recrys
tallized from water to yield 1.7 g (56%) of orange 9.
mp:126-127 C.
1H NMR: (DMSO-d6) 88.15 (s, 1H, NH), 8.01(s, 1H,
H-2), 7.50 (d, 1H, J=8.6 Hz, H-5), 6.97p, (d. 1H, J = 8.8
Hz, H-6), 5.22(s, 1H, OH), 4.41(s, 2H, CH2), 2.96(d,3H,
J=4.7 Hz, CH3). 13C NMR:(DMSO-d6) 8 145.15,
135.70, 130,29, 129.30, 123.44, 114.20, 61.70, 29.69.
Anal. Calcd for C8H4N2O3:C, 52.74; H, 5.53; N, 15.38;
O, 26.35; found: C, 53.02; H, 5.52; N, 15.48; O, 25.98.
4-Methylamino-3-nitrobenzylchloride (10). 1.0 g (5.5

(12). To a solution of 1.0 g (0.88 mmol) of 3-cyclodex
trin in 40 ml DMF was added 35 mg (60% in oil; 0.88
mmol) of NaH and the mixture was stirred overnight
until the solution became clear (11). This solution was
added dropwise to a 5 ml DMF solution containing
0.173 g (0.88 mmol) of 10 and allowed to stand at room
temperature for 30 minutes. B-cyclodextrin and its de
rivatives were precipitated out by addition of 500 ml
acetone. The precipitate was filtered and washed with
100 ml acetone to remove all the unreacted reagent and
to give 1.0 g crude product containing only 12 and
unreacted £3-cyclodextrin as indicated by TLC. The
mixture was separated by Sephadex chromatography to

furnish 0.4 g (35%) of 12, yellow, Rf=0.55, 1H NMR
(DMSO-d6) 88.21 (1H, d, J = 4.7 HZ, N-H), 8.07 (IH, s,
H-2), 7.60 (1H, d, J56=9.0 Hz, H-6), 7.01 (1H, d,

J56=9.0 Hz, H-5), 6.0-3.2 (protons of 3-cyclodextrin),
2.96 (3H, d, J = 4.7 Hz, CH3) Anal. Calcd for
CsohigO3N2.5H2O: C, 42.68; H, 6.45; N, 1.99; O, 48.88;
found: C, 42.83; H, 6.44; N, 1.93; O, 48.80.
Mono-2-flavo-g-cyclodextrin (13). 0.46 g of 12 was

hydrogenated in 80 ml methanol catalyzed by 0.2 g
Pd/C (10%) to yield a colorless solution. The solvent
was evaporated under vacuum below 40' C. and the
residue was washed with 160 ml of acetone. The precip
itate was collected and dried. The crude product was
condensed with 5 g alloxan in 5 ml 1N HCl at refluxing
acetone for 30 minutes. After addition of 100 ml of
acetone, the precipitate was collected and was applied
to a Sephadex (G-25-100) column to yield 30 mg (24%)
of 13, yellow, mp.>250 C., Rf=0.28, 1H NMR
(DMSO-dg) 8 8.15(m, 1H), 7.98(m, 2H), 11.41(s, 1H,
N3-H) and the normal g-cyclodextrin peaks.
13C MNR (DMSO-d6): 8 flavin: 160.2, 156.1, 151.5,
139.1, 136.5, 135.0, 134.7, 133.2, 130.5, 117.0, 32.0(CH3)
and six peaks for the normal g-cyclodextrin at: 102.0,
81.60, 73.10, 72.41, 72.05, 60.00; C-2': 80.01, C-1':
100,02.
FIG. 8 is a 1H NMR spectrum in CD Cls of 8.
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FIG. 9 is a 1H NMR spectrum in DMSO-dg of 9.
FIG. 10 is a 1H NMR spectrum in DMSO-dg of 10.
FIG. 11 is a 1H NMR spectrum in DMSO-dis of 12,

16
EXAMPLE 4

Comparison of Riboflavin and Flavocyclodextrin as
Oxidation Catalysts
The oxidation of substrate benzylmercaptan
(4x10-3M), by riboflavin (5x 105M) and by an artific
ial redox enzyme, 2-flavo-g-cyclodextrin (5X 10-5M
flavin), were compared at pH 10, L=0.68M, 30%

and FIG, 12 is a 13C NMR spectrum in DMSO-d6 of the
same molecule.
FIGS. 13 and 14 are 1H and 13C NMR spectra in
DMSO-d6 of 13.
EXAMPLE 3

Synthesis of Mono-2-flavo-a-cyclodextrin
The a-cyclodextrin analogue of the 2-flavo-3cyclodextrin of Example 2 was synthesized by the same

10

2-O-(4-Methylamino-3-nitro)benzyl-a-cyclodextrin

15

CH3OH at 25 C. by following the decrease of absor
bancy of the thiol group at 440 nm with time.

Kinetic Measurements. Buffers were made up with
distilled water employing reagent grade reagents. All
kinetic studies were carried out at 25-0.1 C. in a

synthetic route.

mixed solvent of MeOH-H2O. Reactions were followed
under anaerobic conditions in stoppered (with SUBA
SEAL SEPTA) cuvettes at 440 nm using Varian 2215

(12). To a solution containing 3.9 g (4.0 mmol) a
cyclodextrin in 40 ml DMF / 40 ml DMSO was added spectrophotometer with a thermostatted cell holder. A
160 mg (60% in oil; 4.0 mmol) of NaH and the mixture typical reaction mixture contained the desired concen
was stirred for 5 hours, 5 ml DMF solution containing 20 tration
of flavin dissolved in 3 ml of buffer in the stop
0.80 g (4.0 mmol) of 10 was added to the solution and it pered cuvette. This solution and substrate solution in
was allowed to stand at room temperature for 1 hour. CH3OH were then deoxygenated separately with a
The cyclodextrin derivatives were precipitated out by stream of argon scrubbed of traces of 02 by means of a

addition of 1L acetone. The precipitate was collected vanadous ion trap for 45 minutes. The reaction was
and washed with acetone to give 4.0 g crude products 25 initiated by injecting substrate solution into cuvette.
containing only 12 and a-cyclodextrin indicated by The data was collected and first order reaction rates
TLC. 50 mg of 12 was isolated from 300 mg crude were calculated with the Kinetic Calc program.
As shown in FIG. 23, the flavocyclodextrin catalyzed
product by Sephadex chromatography. Orange, Rf
a much more rapid and efficient (17-fold) oxidation of
0.56, 1H NMR (D2O) 8
to bis-dibenzylsulfide than did the
13C NMR (D2O)831.2(CH3-), 73.4(CH2), 61.2(C6), 30 benzylmercaptan
natural
riboflavin.
72.5, 72.8, 74.3 (C2, 3, 5), 82.2 (C4), 102.2 (C1), 79.8

(C2), 100.4 (C1), 115.5, 124.9, 127.5, 130.9, 138.6, 147.5

EXAMPLE 5

are 6 61.2, 72.4, 124.9, 112.9, 129.5. CH or CH3 are 8 the
rest of the peaks shown in the above 13C NMR.
Mono-2-flavo-a-cyclodextrin (13). 1.5g of 12 was in
250 ml methanol catalyzed by 0.3 g Pd/C (5%) at-room
temperature for 24 hours until the solution was almost

Lineweaver-Burk Plots for the Oxidation of Benzyl
Mercaptan by Flavocyclodextrin
The concentration of artificial enzyme were kept

for aromatic carbons. APT 13C NMR show: C or CH2
35

constant and the concentration of substrate was varied.
Pseudo-first-order rate constants were obtained from

colorless and then filtered. The filtrate was evaporated
and 20 ml acetone was added to the residue. The precip
itate was then filtered and washed with acetone to give

the decrease in the absorbance at 440 nm which repre
sents the reduction of the flavin. Lineweaver-Burk plots
were obtained by plotting-1/k1 vs. the reciprocal of the
substrate concentration. The straight line thus obtained

rivatives. The precipitate was purified by Sephadex
chromatography to yield 50 mg (40%) of 13, yellow,
Rf 0.24. 1H NMR(D2O). It shows all the normal proton 50
peaks for a-cyclodextrin and 7.22ppm(d, 1H, J=), and
7.38ppm(m, 2H) for flavin. 13C NMR(D2O)
833.0(CH3), 60.3(C6), 71.5, 72.0, 73.3(C2, 3, 5),
81.2(C4), 101.4(C), 79.6(C2), 99.2(CI"), 117.3, 130.3, 55
133.1, 135.2, 1364, 137.0, 137.6, 150.2, 157.6, 1609 for

zylmercaptan (4x103M) by 2-flavo-g-cyclodextrin
(flavin=5x10-5M) at pH 10.0, u=0.68M, 30%

1.5 g precipitate, 0.70 g of the precipitate was allowed
a slope of Kdiss/Kear and a Y intercept equal to
to react with 2.8 g alloxan monohydrate in 10 ml N has
1/k.cat
Kdiss is the dissociation constant of the
HCl for 40 minutes heated by boiling in an acetone bath. 45 artificialwhere
enzyme-substrate complex and kcat is the turn
The solution was cooled with ice-water, and 200 ml
rate for the reaction of complexed substrate.
acetone was added to precipitate the cyclodextrin de over
The Lineweaver-Burk plot for the oxidation of ben
CH3OH in water as solvent, is shown in FIG. 24. The X

and Y values and the gradient and intercept data are
reproduced below.
bnb.enz

Linear Regression
Simple Weighting

flavin. APT 13C NMR show C or CH2 are 8 6 60.3,

133.1, 135.2, 1364, 137.6, 1502,157.6, 1609 CH or CH3

are all the rest of the peaks shown in the above C
NMR.

FIGS. 15 and 16 are the 1H and 3H NMR spectra,
respectively, of the parent a CD (11).
FIGS. 17 and 18 are the H and 3H NMR spectra,
respectively, of the a-CD analogue of 12 of Example 2.
FIG. 19 is the 13C(APT) NMR spectrum of the a-CD
analogue of 12 of Example 2.
FIGS. 20, 21 and 22 are 1H, 13C and 13C(APT) NMR

spectra of the a-CD analogue of 13 of Example 2.
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2
3
4.
s
6
7

Variable
Gradient

Value
1.71397E -- 00

Std. Err.
110622E - 01

Intercept

6.77296E -- 02

1.25296E - O2

X
1.88700E - 03
1.44900E -- 03
1.2500OE - 03

Y
3.73100E -- 03
3.21500E - 03
3.03000E -- 03

1.000.00E -- 03
6.6700OE - O2
5.00000E -- 02
2.50.000E -- 02

2.52000E -1.689.00E 1.4490OE -1.110.00E --

03
03
03
03

Calculated
3.9156E -- 03
3.16084E -- 03
2.81976E -- 03
2.39127E - 03
1.8205E -- 03
1.53428E -- 03
1.10579E - 03
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The k of 1.47 x 10-3s-1 and the Ka of 395.7M-1
7. An artificial redox enzyme of claim 1, 3, 4, 5 or 6,
show that the acceleration in oxidation produced by the wherein said cofactor is electrostatically linked, and
artificial enzyme is brought about by binding and catal wherein
cofactor is selected from the group con
ysis similar to that carried out by natural protein en sisting ofsaid
chromium, manganese, iron, cobalt, nickel,

zymes.

5

EXAMPLE 6

copper,
zinc, rhodium, osmium, palladium and platinum
metal ions.

8. An artificial redox enzyme of claim 1, 3, 4, 5 or 6
wherein said cyclodextrin has hydroxyl groups not

Oxidation of Dihydronaphthylnicotinamide by
2-Flavo-f3-Cyclodextrin
FIG. 25 shows the Lineweaver-Burk plot for the
oxidation of dihydronaphthylnicotinamide (a niacin

10 tized.

in water. The kinetic data are reproduced below.
The ka of 2.82x10-2 s.1 and the Ka of 277M-1

15

nabfirenz

20

linked to said coenzyme or cofactor that are deriva

analogue) at 4x10-3M by 2-flavo-6-cyclodextrin (fla
vin=5x10-5M) at pH 7.0, L=0.08M, in 50% CH3OH
again demonstrate that the artificial enzyme behaves
catalytically as does a natural protein enzyme.
Linear Regression

Simple Weighting

2

Variable
Value
Gradient
2.12613E - 03
Intercept
5.90273E - 01.
X
Y
8.550.00E -- 02
2.44200E -- 00
6.99.000E -- 02
2.00400E -- 00

Std. Err.
108678E - 04
6.45856E - 02
Calculated

25

2.40811E -- 00
2.07644E -- 00

3

5.49000E + 02

1.78300E -- 00

1.75752E -- 00

4.
5

4.270.00E -- 02
2.5000OE -- 02

1.52300E -- 00
1.000E -- 00

1.4983E -- 00
1.1280E -- 00

thereof.
30

We claim:

1. An artificial redox enzyme comprising a S

cyclodextrin covalently or electrostatically linked via
an oxygen atom linked to ring position C-6 of an a-1,4linked D-glucopyranose moiety of said cyclodextrin to

9. An artificial redox enzyme of claim 8, wherein said
derivatized hydroxyl groups are selected from the
group consisting of O-alkyl, O-acyl, O-aryl, O-alkylsul
fonyl, O-arylsulfonyl and O-(trialkylsilyl).
10. An artificial redox enzyme comprising a cy
clodextrin covalently or electrostatically linked via an
oxygen atom linked to ring position C-2 of an a-1,4linked D-glycopyranose moiety of said cyclodextrin to
a redox coenzyme or cofactor.
11. An artificial redox enzyme of claim 10, wherein
said cyclodextrin is selected from the group consisting
of a, As and y-cyclodextrins.
12. An artificial redox enzyme of claim 10, wherein
said redox coenzyme is covalently linked to said oxygen
atom, and wherein said redox coenzyme is selected
from the group consisting of unsubstituted flavins, pyri
dines, pteridines, hemes, coenzyme Q, and derivatives

35

at least one redox coenzyme or cofactor.
2. An artificial redox enzyme of claim 1, wherein said
at least one redox coenzyme is covalently linked to said
oxygen atom, and wherein said at least one redox coen
zyme is selected from the group consisting of unsubsti
tuted flavins, pyridines, pteridines, hemes, coenzyme Q,
and derivatives thereof.
3. An artificial redox enzyme comprising an a 45

cyclodextrin covalently or electrostatically linked via
an oxygen atom linked to ring position C-6 of an a-1,4linked D-glucopyranose moiety of said cyclodextrin to
at least one redox coenzyme or cofactor, wherein said
50
coenzyme is a pyridine or derivative thereof.
4. An artificial redox enzyme comprising an o
cyclodextrin covalently or electrostatically linked via
an oxygen atom linked to ring position C-6 of an a-1,4linked D-glucopyranose moiety of said cyclodextrin to
at least one redox coenzyme or cofactor, wherein said 55
coenzyme is a pteridine or derivative thereof.
5. An artificial redox enzyme comprising an a
cyclodextrin covalently or electrostatically linked via
an oxygen atom linked to ring position C-6 of an a-1,4linked D-glucopyranose moiety of said cyclodextrin to
at least one redox coenzyme or cofactor, wherein said
coenzyme is a heme or derivative thereof.
6. An artificial redox enzyme comprising an a
cyclodextrin covalently or electrostatically linked via
an oxygen atom linked to ring position C-6 of an a-1,4- 65
linked D-glucopyranose moiety of said cyclodextrin to
at least one redox coenzyme or cofactor, wherein said
coenzyme is coenzyme Q or a derivative thereof.

13. An artificial redox enzyme of claim 10, wherein
atom, and wherein said cofactor is selected from the

said cofactor is electrostatically linked to said oxygen

group consisting of chromium, manganese, iron, cobalt,
nickel, copper, rhodium, osmium, palladium and plati
nun metal ions.
14. An artificial redox enzyme of claim 10, wherein
said cyclodextrin has hydroxyl groups not linked to said
coenzyme or cofactor that are derivatized.
15. An artificial redox enzyme of claim 14, wherein
said derivatized hydroxyl groups are selected from the
group consisting of O-alkyl, O-acyl, O-aryl, O-alkylsul
fonyl, O-arylsulfonyl and O-(trialkylsilyl).
16. An artificial redox enzyme comprising a cy
clodextrin covalently or electrostatically linked via an
oxygen atom linked to ring position C-3 of an a-1,4linked D-glucopyranose moiety of said cyclodextrin to

a redox coenzyme or cofactor.
17. An artificial redox enzyme of claim 16, wherein
said cyclodextrin is selected from the group consisting
of a, g and y-cyclodextrins.
18. An artificial redox enzyme of claim 16, wherein

said redox coenzyme is covalently linked to said oxygen
atom, and wherein said redox coenzyme is selected
from the group consisting of unsubstituted flavins, pyri

dines, pteridines, hemes, coenzyme Q, and derivatives
19. An artificial redox enzyme of claim 16, wherein

thereof.

said cofactor is electrostatically linked to said oxygen
atom, and wherein said cofactor is selected from the
group consisting of chromium, manganese, iron, cobalt,
nickel, copper, zinc, rhodium, osmium, palladium and
platinum metal ions.
20. An artificial redox enzyme of claim 16, wherein
said cyclodextrin has hydroxyl groups not linked to said
coenzyme or cofactor that are derivatized.
21. An artificial redox enzyme of claim 20, wherein
said derivatized hydroxyl groups are selected from the
group consisting of O-alkyl, O-acyl, O-aryl, O-alkylsul
fonyl, O-arylsulfonyl and O-(trialkylsilyl).
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and wherein said cofactor is selected from the group
consisting of chromium, manganese, iron, cobalt,
nickel, copper, zinc, rhodium, osmium, palladium and

19
22. An artificial redox enzyme comprising a 2
cyclodextrin covalently or electrostatically linked via
an oxygen atom linked to ring position C-6 of an a-1,4linked D-glucopyranose moiety of said cyclodextrin to
a redox coenzyme or cofactor.
23. An artificial redox enzyme of claim 22, wherein
said redox coenzyme is covalently linked to said oxygen
atom, and wherein said redox coenzyme is selected
from the group consisting of unsubstituted flavins, pyri
dines, pteridines, hemes, coenzyme Q, and derivatives 10

thereof.

24. An artificial redox of claim 22, wherein said co

factor is electrostatically linked to said oxygen atom,
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platinum metal ions.
25. An artificial redox enzyme of claim 22, wherein

said cyclodextrin has hydroxyl groups not linked to said
coenzyme or cofactor that are derivatized.

26. An artificial redox enzyme of claim 25, wherein
said derivatized hydroxyl groups are selected from the
group consisting of O-alkyl, O-acyl, O-aryl, O-alkylsul
fonyl, O-arylsulfonyl and O-(trialkylsilyl).
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